UCI researchers develop novel molecule for COVID-19 treatment Kumar Jeetendra | August 6, 2020 When the coronavirus pandemic struck, nearly everyone in the University of California, Irvine — and colleges across the country — had to abandon campus. That’s because his laboratory, which designs and constructs chemical molecules, had the ideal equipment to aid in the international push to locate remedies for COVID-19. Nowick’s group set to work in …
Quicker Test for Covid-19 Antibodies Kumar Jeetendra | August 5, 2020 A team of Swiss-German researchers has developed a method of testing for neutralizing antibodies against SARS-CoV-2 that creates a result in half the time of traditional tests. A conventional neutralization test to determine immunity to SARS-CoV-2 usually takes two to three days and has to be carried out with infectious coronaviruses in a lab resorting …
BioNTech, Fosun Pharmaceutical dispatch another COVID-19 vaccine trial Kumar Jeetendra | August 5, 2020 Germany’s BioNTech and China’s Shanghai Fosun Pharmaceutical on Wednesday declared the start of another COVID-19 vaccine trial in China with a total of 144 participants. “The study is designed to support the regulatory approval process for the Chinese market and plans to confirm the safety and immunogenicity profile observed in participants in the German and …
Normal cold contamination may prepare the body to perceive novel coronavirus: Study Kumar Jeetendra | August 5, 2020 The body fight it off, also identifies some parts of the novel coronavirus, according to a study whose findings might explain why some individuals have milder COVID-19 cases than others. The research, published in the journal Science, noted that the immune system’s memory T cells keep track of the viruses they’ve seen previously, giving the …
US researchers discover conceivable COVID-19 treatment Kumar Jeetendra | August 4, 2020 Researchers in the US have found a potential therapeutic treatment for SARS-CoV-2, the virus which causes COVID-19, along with other coronaviruses. Pathogenic coronaviruses are a major threat to international public health, as shown by the SARS-CoV, MERS-CoV, along with the recently emerged SARS-CoV-2. All these coronavirus 3C-like proteases, called 3CLpro, are strong therapeutic targets because …
Disposed PPE could be transformed into biofuel, says Indian researchers Kumar Jeetendra | August 4, 2020 Indian scientists have suggested a method to convert the plastic used in personal protective equipment (PPE) into renewable liquid fuels, an advance that could help mitigate the problem of dumped PPE, now being disposed of unprecedented levels because of this COVID-19 pandemic. According to the study, published in the journal Biofuels, billions of items of …
WHO says China group talked with Wuhan researchers over infection sources Kumar Jeetendra | August 4, 2020 A World Health Organization team in China to research the roots of COVID-19 had”extensive discussions” and exchanges with scientists in Wuhan in which the outbreak was first detected, a spokesman said on Tuesday. The talks included updates on animal health study, he said. China shut down a wildlife market in Wuhan in the start of …
Protein delivered by the human safe framework can emphatically hinder Sars-Cov-2 Kumar Jeetendra | August 3, 2020 A protein produced by the human immune system may strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19. An international team from Germany, Switzerland and the USA successfully showed the LY6E-Protein prevents coronaviruses from causing the illness. “This finding may result in the development of new therapeutic approaches against coronaviruses,” says Professor Stephanie Pfänder …
Serum Institute gets DCGI gesture for stage 2 and 3 human clinical preliminaries of Oxford’s coronavirus immunization Kumar Jeetendra | August 3, 2020 The Drugs Controller General of India (DCGI) has contributed nod to the Serum Institute of India (SII) for conducting phase 3 and 2 human clinical trials of a COVID-19 vaccine candidate, developed at the University of Oxford, in the country. Government officials told PTI that the approval of conducting stage 2 and 3 clinical trials …
Aerogen – bringing a lower risk of transmission of patient generated infectious aerosol for healthcare professionals in acute care settings compared to traditional nebulisers Kumar Jeetendra | August 3, 2020 India has 18% of the global population and an increasing burden of chronic respiratory diseases1. The technique of nebulisation is commonly utilised in the treatment of such diseases including asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD)2. Recent improvements in nebuliser technologies have led to the development of vibrating mesh nebulisers (VMNs) that produce …
Sterile 96-Well Plate Seal for Cell Culturing by BioChromato Kumar Jeetendra | August 2, 2020 BioChromato, Fujisawa, Japan, has introduced a gamma sterilized version of its Rapid Slit Seal for scientists seeking to eliminate solvent evaporation from samples when culturing cells from 96-well microplates. Rapid Slit Seal is a proprietary self-closing microplate seal which returns to its initial state even when punched having an HPLC or even LC/MS autosampler. This …
FDA authorizes initial two COVID-19 serology tests Kumar Jeetendra | August 2, 2020 Today, the U.S. Food and Drug Administration approved the initial two COVID-19 serology tests which show an estimated amount of antibodies within somebody’s blood. Both tests from Siemens, the ADVIA Centaur COV2G and Attelica COV2G are what are known as”semi-quantitative” evaluations, meaning that they don’t show an exact measurement, but estimate the number of a …
